Irbesartan and Hydrochlorothiazide
- Product NDC
- 42291-342
- 11-digit product format
- 422910342
- Labeler code
- 42291
- Product ID
- 42291-342_c7026713-be19-7fda-e053-2a95a90a2717
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Irbesartan and Hydrochlorothiazide
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA077369
- Marketing category
- ANDA
- Marketing start
- 2013-07-22
- Marketing end
- 0000-00-00
- Substance
- IRBESARTAN; HYDROCHLOROTHIAZIDE
- Active strength
- 150 mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-342-90 | 42291034290 | 90 TABLET, FILM COATED in 1 BOTTLE (42291-342-90) | 2013-07-22 | 0000-00-00 | No | No | Current |